NDAORALSOLUTION
Approved
Feb 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Potassium iodide is an oral solution containing iodine used to treat non-Hodgkin lymphoma and neuroblastoma. The exact mechanism of action is not specified in available data, but iodide compounds are used in oncology for their potential anti-proliferative effects. This is a legacy oral small-molecule therapy approved over 40 years ago.
LOE Approaching
Product faces imminent loss of exclusivity with moderate competitive pressure (30%), suggesting defensive positioning and potential headcount rationalization on the brand team.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Career opportunities are concentrated in manufacturing and quality operations rather than commercial or medical roles, reflecting the product's mature, low-growth status. Working on potassium iodide offers limited visibility for commercial advancement or strategic product leadership.
Quality Assurance ManagerLine Operator
Worked on POTASSIUM IODIDE at Mission Pharmacal? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.